Multidrug therapy for leprosy patients in Brazil
16 Jul, 2017 | 23:47h | UTCUniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients – PLOS One (free) (RT @Onisillos)
Related WHO reports: Operational Manual 2016 – Global Leprosy Strategy 2016−2020 (free) AND Global Leprosy Strategy 2016−2020: Accelerating towards a leprosy-free world (free)
“Shorter courses Rx possible for Leprosy: Very important result” (RT @dr_michaelmarks see Tweet)